Ensysce Biosciences, Inc.

Biotechnology • Healthcare • La Jolla, CA, United States • ENSCW (PNK)

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology. The company's lead product candidate is PF614, a TAAP oxycodone prodrug candidate for the treatment of severe or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat for overdose protection. It is also developing PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for attention deficit hyperactivity disorder; and PF9001 to treat Opioid use disorder.Ensysce Biosciences, Inc. was founded in 2003 and is based in La Jolla, California.

858 263 4196 7946 Ivanhoe Avenue, La Jolla, CA 92037, United States

Stock Performance (90 Days)

Data through Oct 22, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Ensysce Biosciences (NASDAQ: ENSC) begins Phase 3 PF614 trial; Q3 net loss $3.7M - Stock Titan

Stock Titan • Nov 14

Should You Buy Ensysce Biosciences After Share Sale? - StocksToTrade

StocksToTrade • Dec 9

Ensysce Biosciences Narrows Loss in Q2 - Nasdaq

Nasdaq • Aug 13

Is Ensysce Biosciences a Hidden Gem? - timothysykes.com

timothysykes.com • Dec 9

Ensysce Biosciences Stock Rises On Positive Data From Opioid Overdose Protection Study: Retail’s Thrilled - Stocktwits

Stocktwits • Apr 15

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Ensysce Biosciences, Inc. had layoffs?

No layoff events have been recorded for Ensysce Biosciences, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Ensysce Biosciences, Inc. have?

Ensysce Biosciences, Inc. has approximately 7 employees.

What industry is Ensysce Biosciences, Inc. in?

Ensysce Biosciences, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Ensysce Biosciences, Inc. a publicly traded company?

Yes, Ensysce Biosciences, Inc. is publicly traded under the ticker symbol ENSCW on the PNK.

Where is Ensysce Biosciences, Inc. headquartered?

Ensysce Biosciences, Inc. is headquartered in La Jolla, CA, United States at 7946 Ivanhoe Avenue, La Jolla, CA 92037, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.